TY - JOUR
T1 - Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production
AU - Viaud, Manon
AU - Ivanov, Stoyan
AU - Vujic, Nemanja
AU - Duta-Mare, Madalina
AU - Aira, Lazaro Emilio
AU - Barouillet, Thibault
AU - Garcia, Elsa
AU - Orange, Francois
AU - Dugail, Isabelle
AU - Hainault, Isabelle
AU - Stehlik, Christian
AU - Marchetti, Sandrine
AU - Boyer, Laurent
AU - Guinamard, Rodolphe
AU - Foufelle, Fabienne
AU - Bochem, Andrea
AU - Hovingh, Kees G.
AU - Thorp, Edward B.
AU - Gautier, Emmanuel L.
AU - Kratky, Dagmar
AU - Dasilva-Jardine, Paul
AU - Yvan-Charvet, Laurent
N1 - Funding Information:
The Fondation ARC (Association pour la Recherche sur le Cancer; RAC15014AAA) and the Austrian Science Fund (W1226 DK-MCD) support L. Boyer and D. Kratky, respectively. PACA region PhD fellowship supports M. Viaud, and BioTechMed-Graz (Flagship) supports N. Vujic and M. Duta-Mare fellowships. BioTechMed-Graz (Flagship Lipases and Lipid Signaling) supports D. Kratky. This work was supported by the Inserm Atip-Avenir program, the association VML (Vaincre les Maladies Lysosomales), the European Marie Curie Career Integration Grant (CIG-630926), and the Agence Nationale de la Recherche (ANR-14-CE12-0017-01) to L. Yvan-Charvet.
Funding Information:
We thank Dr Wanida Ruangsiriluk for providing lysosomal acid lipase (LIPA)-overexpressing THP-1 macrophages and very useful scientific discussion and advice. We thank Dr Fréderic Larbret for assistance with flow cytometry and Dr Véronique Corcelle for assistance in animal facilities. The Fondation ARC (Association pour la Recherche sur le Cancer; RAC15014AAA) and the Austrian Science Fund (W1226 DK-MCD) support L. Boyer and D. Kratky, respectively. PACA region PhD fellowship supports M. Viaud, and BioTechMed-Graz (Flagship) supports N. Vujic and M. Duta-Mare fellowships. BioTechMed-Graz (Flagship Lipases and Lipid Signaling) supports D. Kratky. This work was supported by the Inserm Atip-Avenir program, the association VML (Vaincre les Maladies Lysosomales), the European Marie Curie Career Integration Grant (CIG-630926), and the Agence Nationale de la Recherche (ANR-14-CE12-0017-01) to L. Yvan-Charvet.
Publisher Copyright:
© 2018 American Heart Association, Inc.
PY - 2018/5
Y1 - 2018/5
N2 - Rationale: Macrophages face a substantial amount of cholesterol after the ingestion of apoptotic cells, and the LIPA (lysosomal acid lipase) has a major role in hydrolyzing cholesteryl esters in the endocytic compartment. Objective: Here, we directly investigated the role of LIPA-mediated clearance of apoptotic cells both in vitro and in vivo. Methods and Results: We show that LIPA inhibition causes a defective efferocytic response because of impaired generation of 25-hydroxycholesterol and 27-hydroxycholesterol. Reduced synthesis of 25-hydroxycholesterol after LIPA inhibition contributed to defective mitochondria-associated membrane leading to mitochondrial oxidative stress-induced NLRP3 (NOD-like receptor family, pyrin domain containing) inflammasome activation and caspase-1-dependent Rac1 (Ras-related C3 botulinum toxin substrate 1) degradation. A secondary event consisting of failure to appropriately activate liver X receptor-mediated pathways led to mitigation of cholesterol efflux and apoptotic cell clearance. In mice, LIPA inhibition caused defective clearance of apoptotic lymphocytes and stressed erythrocytes by hepatic and splenic macrophages, culminating in splenomegaly and splenic iron accumulation under hypercholesterolemia. Conclusions: Our findings position lysosomal cholesterol hydrolysis as a critical process that prevents metabolic inflammation by enabling efficient macrophage apoptotic cell clearance.
AB - Rationale: Macrophages face a substantial amount of cholesterol after the ingestion of apoptotic cells, and the LIPA (lysosomal acid lipase) has a major role in hydrolyzing cholesteryl esters in the endocytic compartment. Objective: Here, we directly investigated the role of LIPA-mediated clearance of apoptotic cells both in vitro and in vivo. Methods and Results: We show that LIPA inhibition causes a defective efferocytic response because of impaired generation of 25-hydroxycholesterol and 27-hydroxycholesterol. Reduced synthesis of 25-hydroxycholesterol after LIPA inhibition contributed to defective mitochondria-associated membrane leading to mitochondrial oxidative stress-induced NLRP3 (NOD-like receptor family, pyrin domain containing) inflammasome activation and caspase-1-dependent Rac1 (Ras-related C3 botulinum toxin substrate 1) degradation. A secondary event consisting of failure to appropriately activate liver X receptor-mediated pathways led to mitigation of cholesterol efflux and apoptotic cell clearance. In mice, LIPA inhibition caused defective clearance of apoptotic lymphocytes and stressed erythrocytes by hepatic and splenic macrophages, culminating in splenomegaly and splenic iron accumulation under hypercholesterolemia. Conclusions: Our findings position lysosomal cholesterol hydrolysis as a critical process that prevents metabolic inflammation by enabling efficient macrophage apoptotic cell clearance.
KW - Cholesterol
KW - Inflammation
KW - Macrophage
KW - Mitochondria
KW - Oxysterols
UR - http://www.scopus.com/inward/record.url?scp=85052439024&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052439024&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.117.312333
DO - 10.1161/CIRCRESAHA.117.312333
M3 - Article
C2 - 29523554
AN - SCOPUS:85052439024
SN - 0009-7330
VL - 122
SP - 1369
EP - 1384
JO - Circulation Research
JF - Circulation Research
IS - 10
ER -